Cisplatin API
| Name of Product | Cisplatin API |
|---|---|
| CAS No | 15663‑27‑1 |
| Therapeutic use:- | Platinum coordination complex; antineoplastic used in various solid tumors |
| Grade | IP/USP/EP/BP |
| Form:- | API Powder |
| Status | Regular |
Product Overview
Cisplatin API is a type of chemotherapy drug that is based on platinum and is in the same group as alkylating-like drugs.
One of the most widely used platinum-based chemotherapies in oncology.
It acts by stopping DNA from copying and transcribing itself.
This action causes cancer cells that are dividing quickly to die in a planned way (apoptosis).
In the 1970s, Cisplatin API was initially approved. It is still a very important treatment for many solid cancers.
Because it functions well enough and is widely utilised, it is a standard part of cancer care.
Therapeutic Applications
Therapeutic class: Antineoplastic agent
Specification Parameters
Quality and technical specifications that are common for Cisplatin:
Packaging & Storage
Cisplatin is packaged according to international rules and safety markings for the pharmaceutical market:
Packaging options include sterile vials, which are usually made to order according to what the client needs.
Type of container, such as amber glass vials or infusion bottles, to keep out light.
Each item is in its own box with protective padding to keep it safe while shipping.
Keep at a controlled room temperature of 15°C to 25°C.
Keep away from light and wetness.
Do not let unauthorized people get to it.
